In 2010, a study examined a LEPR polymorphism involving a glutamine-to-arginine substitution at codon 223 (Gln223Arg) in a Japanese population with late-onset AD (LOAD) and reported no significant association with disease risk [303]. The gene discussed is LEPR; the disease is Alzheimer disease.